Literature DB >> 165859

Editorial: Miracle cures in Parkinson's disease.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 165859      PMCID: PMC1673696          DOI: 10.1136/bmj.3.5974.1

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  19 in total

1.  Effect of adrenergic beta-blockade on parkinsonian tremor.

Authors:  D A Owen; C D Marsden
Journal:  Lancet       Date:  1965-12-18       Impact factor: 79.321

2.  3-Hydroxy-4-methoxyphenethylamine: the endogenous toxin of parkinsonism?

Authors:  B C Barrass; D B Coult; R M Pinder
Journal:  J Pharm Pharmacol       Date:  1972-06       Impact factor: 3.765

3.  Cholinergic-anticholinergic antagonism in parkinsonism.

Authors:  R C Duvoisin
Journal:  Arch Neurol       Date:  1967-08

4.  Letter: Intravenous thyrotrophin-releasing hormone in Parkinson's disease.

Authors:  J A McCaul; K J Cassell; G M Stern
Journal:  Lancet       Date:  1974-04-20       Impact factor: 79.321

5.  Melanocyte-stimulating hormone and parkinsonism.

Authors:  S Shuster; A J Thody; S K Goolamali; J L Burton; N Plummer; D Bates
Journal:  Lancet       Date:  1973-03-03       Impact factor: 79.321

6.  Café-au-lait spots and vitiligo in Parkinson's disease.

Authors:  J D Parkes; D Vollum; C D Marsden; A C Branfoot
Journal:  Lancet       Date:  1972-12-23       Impact factor: 79.321

7.  Melatonin and parkinsonism.

Authors:  K M Shaw; G M Stern; M Sandler
Journal:  Lancet       Date:  1973-02-03       Impact factor: 79.321

Review 8.  Parkinsonism--neuropathology.

Authors:  P D Lewis
Journal:  Br Med J       Date:  1971-09-18

9.  Aberrant mRNA in Parkinsonism: support for hypothesis from studies with chloramphenicol.

Authors:  C N Stefanis; M Issidorides
Journal:  Nature       Date:  1970-03-07       Impact factor: 49.962

10.  Melatonin and parkinsonism.

Authors:  P S Papavasiliou; G C Cotzias; S E Düby; A J Steck; M Bell; W H Lawrence
Journal:  JAMA       Date:  1972-07-03       Impact factor: 56.272

View more
  1 in total

Review 1.  Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.